Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter of fiscal
MEDS Earnings: Highlights of Trxade Health’s Q2 2023 financial results
Categories
Health Care
Agilent Technologies Inc Q3 2023 Earnings Conference Call Insights
Key highlights from Agilent Technologies Inc (A) Q3 2023 Earnings Concall Management Update: [00:04:02] A said it now expects core growth for
Earnings: All you need to know about Agilent Technologies’ Q3 2023 results
Agilent Technologies (NYSE: A) on Tuesday reported mixed results for the third quarter of 2023 when the medical device company's adjusted earnings
Cardinal Health Inc Q4 2023 Earnings Conference Call Insights
Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including its highest
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in the
Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit. Revenues
Illumina, Inc Q2 2023 Earnings Conference Call Insights
Key highlights from Illumina, Inc (ILMN) Q2 2023 Earnings Concall Management Update: [00:07:42] ILMN now expects to ship more than 390 NovaSeq
Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and multiple cancers.
Earnings Summary: Highlights of Illumina’s Q2 2023 results
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came in at
Earnings Summary: Highlights of Organon’s Q2 2023 results
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter revenue came
Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights
Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim asked if
Earnings Summary: Charles River Laboratories reports Q2 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023. For the
Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the latest such
Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and share price
Eli Lilly and Company Q2 2023 Earnings Conference Call Insights
Key highlights from Eli Lilly and Company (LLY) Q2 2023 Earnings Concall Q&A Highlights: [00:36:01] Louise Chen from Kantor asked about the
Earnings Summary: Bio-Techne Corp (TECH) reports higher Q4 profit, revenue
Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Tuesday announced financial results for the fourth quarter of 2023, reporting an increase in profit.
Earnings Summary: Zoetis (ZTS) reports fiscal 2023 Q2 results
Animal healthcare company Zoetis Inc. (NYSE: ZTS) announced operating results for the second quarter, reporting higher adjusted profit and sales. Zoetis' June-quarter
LLY Earnings: Key quarterly highlights from Eli Lilly’s Q2 2023 financial results
Eli Lilly and Company (NYSE: LLY) reported second quarter 2023 earnings results today. Revenue increased 28% to $8.3 billion compared to the
AMGN Earnings: Everything you need to know about Amgen’s Q2 results
Amgen Inc. (NASDAQ: AMGN) on Friday reported higher revenues and adjusted earnings for the second quarter of 2023. The biotechnology firm also
Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers
Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up 5% year-over-year.
Cigna Corporation Q2 2023 Earnings Conference Call Insights
Key highlights from Cigna Corporation (CI) Q2 2023 Earnings Concall Q&A Highlights: [00:21:37] Scott Fidel with Stephens asked how are underlying utilization